Iteos Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ITOS

*Your capital is at risk

$10.15

+0 (+0%)

At Close: Nov 28, 2025

Currently predicting for Fri, 5 Jun 2026

ITOS Prediction Chart

ITOS Predictions History

Latest community submissions for ITOS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Aug 25, 2021	$26.91 -1.03%	$27.19	X	98.97%	2
sander7100 yo bro Pro @sander7100yobro.167552	Aug 25, 2021	$550.03 +1 922.91% Unrealistic Excluded from avg	$27.19	X	0.00%	0
Ronald Curtis @RonaldCurtis.254553	Aug 25, 2021	Bullish	$27.19	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ITOS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ITEOS THERAPEUTICS INC.

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used t...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by